Mode
Text Size
Log in / Sign up
Phase 3 N=87 Randomized Single-blind Treatment

An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence

Urinary Incontinence

Enrolled (actual)
87
Serious AEs
0.0%
Results posted
Oct 2013
Primary outcome: Primary: Number of Leaks Per Day — NA; NA Number of Leaks Per Day

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
bion (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Boston Scientific Corporation
Primary completion
Jul 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Leaks Per Day
NA; NA
PRIMARY
Freedom From Major Complications
0; 0

Summary

This clinical trial is being conducted to investigate the safety and effectiveness of a new device designed to treat urinary urge incontinence in those patients who have tried and failed two or more conservative therapies.

Eligibility Criteria

Key Inclusion Criteria

  • Age 18 years and above.
  • Diagnosed with urinary urge incontinence.
  • Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor.
  • Have normal upper urinary tract function.
  • Be capable of giving informed consent.
  • Be capable and willing to follow all study related procedures.

Key Exclusion Criteria

  • Have any active implantable device regardless of whether stimulation status is ON or OFF.
  • Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 months period.
  • Less than one year post partum and/or are breast-feeding.
  • Have any passive implant that contains metal or electrically conductive materials.
  • Have conditions requiring Magnetic Resonance Imaging (MRI) evaluation.
  • Have conditions requiring diathermy procedures.
  • Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver.
  • Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes.
  • Have history of coagulopathy or bleeding disorder.
  • Have a history of pelvic pain as primary diagnosis.
  • Have anatomical restrictions such that the study device placement is not possible.
  • Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function.
  • Have a life expectancy of less than 1 year.
  • Cannot independently comprehend and complete the QoL questionnaires.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00080470). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search